1
|
Sun B, Zheng X, Zhang X, Zhang H, Jiang Y. Oxaliplatin-Loaded Mil-100(Fe) for Chemotherapy-Ferroptosis Combined Therapy for Gastric Cancer. ACS OMEGA 2024; 9:16676-16686. [PMID: 38617668 PMCID: PMC11007804 DOI: 10.1021/acsomega.4c00658] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/20/2024] [Revised: 02/26/2024] [Accepted: 03/19/2024] [Indexed: 04/16/2024]
Abstract
Oxaliplatin (Oxa) is a commonly used chemotherapy drug in the treatment of gastric cancer, but its toxic side effects and drug resistance after long-term use have seriously limited its efficacy. Loading chemotherapy drugs with nanomaterials and delivering them to the tumor site are common ways to overcome the above problems. However, nanomaterials as carriers do not have therapeutic functions on their own, and the effect of single chemotherapy is relatively limited, so there is still room for progress in related research. Herein, we construct Oxa@Mil-100(Fe) nanocomposites by loading Oxa with a metal-organic framework (MOF) Mil-100(Fe) with high biocompatibility and a large specific surface area. The pore structure of Mil-100(Fe) is conducive to a large amount of Oxa loading with a drug-loading rate of up to 27.2%. Oxa@Mil-100(Fe) is responsive to the tumor microenvironment (TME) and can release Oxa and Fe3+ under external stimulation. On the one hand, Oxa can inhibit the synthesis of DNA and induce the apoptosis of gastric cancer cells. On the other hand, Fe3+ can clear overexpressed glutathione (GSH) in TME and be reduced to Fe2+, inhibiting the activity of glutathione peroxidase 4 (GPX4), leading to the accumulation of intracellular lipid peroxides (LPO), and at the same time releasing a large number of reactive oxygen species (ROS) through the Fenton reaction, inducing ferroptosis in gastric cancer cells. With the combination of apoptosis and ferroptosis, Oxa@Mil-100(Fe) shows a good therapeutic effect, and the killing effect on gastric cancer cells is obvious. In a nude mouse model of subcutaneous tumor transplantation, Oxa@Mil-100(Fe) shows a significant inhibitory effect on tumor growth, with an inhibition rate of nearly 60%. In addition to its excellent antitumor activity, Oxa@Mil-100(Fe) has no obvious toxic or side effects. This study provides a new idea and method for the combined treatment of gastric cancer.
Collapse
Affiliation(s)
- Boyao Sun
- Department
of Gastrointestinal and Colorectal Surgery, China-Japan Union Hospital of Jilin University, Changchun 130031, P. R. China
| | - Xuewei Zheng
- Department
of Radiology, China-Japan Union Hospital
of Jilin University, Changchun 130031, P. R. China
| | - Xiaoyu Zhang
- Department
of Gastrointestinal and Colorectal Surgery, China-Japan Union Hospital of Jilin University, Changchun 130031, P. R. China
| | - Huaiyu Zhang
- Department
of Rehabilitation Medicine, China-Japan
Union Hospital of Jilin University, Changchun 130031, P. R. China
| | - Yang Jiang
- Department
of Gastrointestinal and Colorectal Surgery, China-Japan Union Hospital of Jilin University, Changchun 130031, P. R. China
| |
Collapse
|
2
|
Oryani MA, Nosrati S, Javid H, Mehri A, Hashemzadeh A, Karimi-Shahri M. Targeted cancer treatment using folate-conjugated sponge-like ZIF-8 nanoparticles: a review. NAUNYN-SCHMIEDEBERG'S ARCHIVES OF PHARMACOLOGY 2024; 397:1377-1404. [PMID: 37715816 DOI: 10.1007/s00210-023-02707-y] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/13/2023] [Accepted: 09/02/2023] [Indexed: 09/18/2023]
Abstract
ZIF-8 (zeolitic imidazolate framework-8) is a potential drug delivery system because of its unique properties, which include a large surface area, a large pore capacity, a large loading capacity, and outstanding stability under physiological conditions. ZIF-8 nanoparticles may be readily functionalized with targeting ligands for the identification and absorption of particular cancer cells, enhancing the efficacy of chemotherapeutic medicines and reducing adverse effects. ZIF-8 is also pH-responsive, allowing medication release in the acidic milieu of cancer cells. Because of its tunable structure, it can be easily functionalized to design cancer-specific targeted medicines. The delivery of ZIF-8 to cancer cells can be facilitated by folic acid-conjugation. Hence, it can bind to overexpressed folate receptors on the surface of cancer cells, which holds the promise of reducing unwanted deliveries. As a result of its importance in cancer treatment, the folate-conjugated ZIF-8 was the major focus of this review.
Collapse
Affiliation(s)
- Mahsa Akbari Oryani
- Department of Pathology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Shamim Nosrati
- Department of Clinical Biochemistry, Faculty of Medicine, Azad Shahroud University, Shahroud, Iran
| | - Hossein Javid
- Department of Medical Laboratory Sciences, Varastegan Institute for Medical Sciences, Mashhad, Iran.
- Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
- Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
| | - Ali Mehri
- Endoscopic and Minimally Invasive Surgery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Alireza Hashemzadeh
- Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Mehdi Karimi-Shahri
- Department of Pathology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
- Department of Pathology, School of Medicine, Gonabad University of Medical Sciences, Gonabad, Iran.
| |
Collapse
|
3
|
Parsaei M, Akhbari K, Tylianakis E, Froudakis GE. Effects of Fluorinated Functionalization of Linker on Quercetin Encapsulation, Release and Hela Cell Cytotoxicity of Cu-Based MOFs as Smart pH-Stimuli Nanocarriers. Chemistry 2024; 30:e202301630. [PMID: 37581254 DOI: 10.1002/chem.202301630] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2023] [Revised: 08/13/2023] [Accepted: 08/14/2023] [Indexed: 08/16/2023]
Abstract
Controlled delivery of target molecules is required in many medical and chemical applications. For such purposes, metal-organic frameworks (MOFs), which possess desirable features such as high porosity, large surface area, and adjustable functionalities, hold great potential as drug carriers. Herein, Quercetin (QU), as an anticancer drug, was loaded on Cu2 (BDC)2 (DABCO) and Cu2 (F4 BDC)2 )DABCO) MOFs (BDC=1,4-benzenedicarboxylate and DABCO=1,4-diazabicyclo[2.2.2]octane). As these Cu-MOFs have a high surface area, an appropriate pore size, and biocompatible ingredients, they can be utilized to deliver QU. The loading efficiency of QU in these MOFs was 49.5 % and 41.3 %, respectively. The drug-loaded compounds displayed sustained drug release over 15 days, remarkably high drug loading capacities and pH-controlled release behavior. The prepared nanostructures were characterized by different characterization technics including FT-IR, PXRD, ZP, TEM, FE-SEM, UV-vis, and BET. In addition, MTT assays were carried out on the HEK-293 and HeLa cell lines to investigate cytotoxicity. Cellular apoptosis analysis was performed to investigate the cell death mechanisms. Grand Canonical Monte Carlo simulations were conducted to analyze the interactions between MOFs and QU. Moreover, the stability of MOFs was also investigated during and after the drug release process. Ultimately, kinetic models of drug release were evaluated.
Collapse
Affiliation(s)
- Mozhgan Parsaei
- School of Chemistry, College of Science, University of Tehran, 14155-6455, Tehran, Iran
| | - Kamran Akhbari
- School of Chemistry, College of Science, University of Tehran, 14155-6455, Tehran, Iran
| | - Emmanuel Tylianakis
- Department of Materials Science and Technology, Voutes Campus, University of Crete, GR-71003 Heraklion, Crete, Greece
| | - George E Froudakis
- Department of Chemistry, Voutes Campus, University of Crete, GR-71003 Heraklion, Crete, Greece
| |
Collapse
|
4
|
Zhang Y, Sun M, Zhao H, Wang Z, Shi Y, Dong J, Wang K, Wang X, Li X, Qi H, Zhao X. Neuroprotective Effects and Therapeutic Potential of Dichloroacetate: Targeting Metabolic Disorders in Nervous System Diseases. Int J Nanomedicine 2023; 18:7559-7581. [PMID: 38106446 PMCID: PMC10725694 DOI: 10.2147/ijn.s439728] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2023] [Accepted: 11/28/2023] [Indexed: 12/19/2023] Open
Abstract
Dichloroacetate (DCA) is an investigational drug used to treat lactic acidosis and malignant tumours. It works by inhibiting pyruvate dehydrogenase kinase and increasing the rate of glucose oxidation. Some studies have documented the neuroprotective benefits of DCA. By reviewing these studies, this paper shows that DCA has multiple pharmacological activities, including regulating metabolism, ameliorating oxidative stress, attenuating neuroinflammation, inhibiting apoptosis, decreasing autophagy, protecting the blood‒brain barrier, improving the function of endothelial progenitor cells, improving mitochondrial dynamics, and decreasing amyloid β-protein. In addition, DCA inhibits the enzyme that metabolizes it, which leads to peripheral neurotoxicity due to drug accumulation that may be solved by individualized drug delivery and nanovesicle delivery. In summary, in this review, we analyse the mechanisms of neuroprotection by DCA in different diseases and discuss the causes of and solutions to its adverse effects.
Collapse
Affiliation(s)
- Yue Zhang
- Department of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, People’s Republic of China
- Laboratory of Anesthesia and Critical Care Medicine in Colleges and Universities of Shandong Province, School of Anesthesiology, Weifang Medical University, Weifang, Shandong Province, People’s Republic of China
| | - Meiyan Sun
- Laboratory of Anesthesia and Critical Care Medicine in Colleges and Universities of Shandong Province, School of Anesthesiology, Weifang Medical University, Weifang, Shandong Province, People’s Republic of China
| | - Hongxiang Zhao
- Department of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, People’s Republic of China
- Laboratory of Anesthesia and Critical Care Medicine in Colleges and Universities of Shandong Province, School of Anesthesiology, Weifang Medical University, Weifang, Shandong Province, People’s Republic of China
| | - Zhengyan Wang
- Laboratory of Anesthesia and Critical Care Medicine in Colleges and Universities of Shandong Province, School of Anesthesiology, Weifang Medical University, Weifang, Shandong Province, People’s Republic of China
| | - Yanan Shi
- Laboratory of Anesthesia and Critical Care Medicine in Colleges and Universities of Shandong Province, School of Anesthesiology, Weifang Medical University, Weifang, Shandong Province, People’s Republic of China
| | - Jianxin Dong
- Laboratory of Anesthesia and Critical Care Medicine in Colleges and Universities of Shandong Province, School of Anesthesiology, Weifang Medical University, Weifang, Shandong Province, People’s Republic of China
| | - Kaifang Wang
- Department of Anesthesia, Tangdu Hospital, Fourth Military Medical University, Xian, Shanxi Province, People’s Republic of China
| | - Xi Wang
- Department of Anesthesiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, People’s Republic of China
| | - Xingyue Li
- Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Weifang Medical University, Weifang, Shandong Province, People’s Republic of China
| | - Haiyan Qi
- Department of Anesthesiology, Jinan Maternity and Child Care Hospital Affiliated to Shandong First Medical University, Jinan, Shandong Province, People’s Republic of China
| | - Xiaoyong Zhao
- Department of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, People’s Republic of China
- Laboratory of Anesthesia and Critical Care Medicine in Colleges and Universities of Shandong Province, School of Anesthesiology, Weifang Medical University, Weifang, Shandong Province, People’s Republic of China
- Department of Anesthesiology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong Province, People’s Republic of China
| |
Collapse
|
5
|
Abánades Lázaro I, Vicent-Morales M, Mínguez Espallargas G, Giménez-Marqués M. Hierarchical mesoporous NanoMUV-2 for the selective delivery of macromolecular drugs. J Mater Chem B 2023; 11:9179-9184. [PMID: 37718709 DOI: 10.1039/d3tb01819a] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/19/2023]
Abstract
Although Metal-organic frameworks (MOFs) have received attention as drug delivery systems, their application in the delivery of macromolecules is limited by their pore size and opening. Herein, we present the synthesis of nanostructured MUV-2, a hierarchical mesoporous iron-based MOF that can store high payloads of the macromolecular drug paclitaxel (ca. 23% w/w), increasing its selectivity towards HeLa cancer cells over HEK non-cancerous cells. Moreover, this NanoMUV-2 permits full degradation under simulated physiological conditions while maintaining biocompatibility, and is amenable to specific surface modifications that increase its cell permeation, efficient cytosol delivery and cancer-targeting effect, further intensifying the cancer selectivity of paclitaxel.
Collapse
Affiliation(s)
- Isabel Abánades Lázaro
- Instituto de Ciencia Molecular (ICMol), Universitat de València, Catedrático José Beltrán Martínez No 2, 46980 Paterna, Valencia, Spain.
| | - María Vicent-Morales
- Instituto de Ciencia Molecular (ICMol), Universitat de València, Catedrático José Beltrán Martínez No 2, 46980 Paterna, Valencia, Spain.
| | - Guillermo Mínguez Espallargas
- Instituto de Ciencia Molecular (ICMol), Universitat de València, Catedrático José Beltrán Martínez No 2, 46980 Paterna, Valencia, Spain.
| | - Mónica Giménez-Marqués
- Instituto de Ciencia Molecular (ICMol), Universitat de València, Catedrático José Beltrán Martínez No 2, 46980 Paterna, Valencia, Spain.
| |
Collapse
|
6
|
Yadav P, Kumari S, Yadav A, Bhardwaj P, Maruthi M, Chakraborty A, Kanoo P. Biocompatible Drug Delivery System Based on a MOF Platform for a Sustained and Controlled Release of the Poorly Soluble Drug Norfloxacin. ACS OMEGA 2023; 8:28367-28375. [PMID: 37576664 PMCID: PMC10413448 DOI: 10.1021/acsomega.3c02418] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/10/2023] [Accepted: 07/14/2023] [Indexed: 08/15/2023]
Abstract
Norfloxacin (NFX), an important antibacterial fluoroquinolone, is a class IV drug according to the biopharmaceutics classification system (BCS) and has low solubility and permeability issues. Such poor physicochemical properties of drug molecules lead to poor delivery and are of serious concern to the pharmaceutical industry for clinical development. We present here a conceptually new approach to deliver NFX, by loading the drug molecule on the porous platform of a biocompatible metal-organic framework (MOF), MIL-100(Fe). The loading of the drug on the MOF leading to NFX@MIL-100(Fe) was characterized by Fourier transform infrared (FTIR), UV-visible spectroscopy, thermogravimetric analyses (TGA), and nitrogen adsorption studies. Controlled experiments resulted in the high loading of the drug molecule (∼20 wt %) along with the desired sustained release. We could further control the release of norfloxacin by coating drug-loaded MIL-100(Fe) with PEG, PEG{NFX@MIL-100(Fe)}. Both drug delivery systems (DDSs), NFX@MIL-100(Fe) and PEG{NFX@MIL-100(Fe)}, were tested for their biocompatibility through toxicity studies. The DDSs are biocompatible and show insignificant cytotoxicity, as revealed by cell viability studies through the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay.
Collapse
Affiliation(s)
- Preety Yadav
- Department
of Chemistry, School of Basic Sciences, Central University of Haryana, Jant-Pali, Mahendergarh 123031, Haryana, India
| | - Sarita Kumari
- Department
of Chemistry, School of Basic Sciences, Central University of Haryana, Jant-Pali, Mahendergarh 123031, Haryana, India
| | - Anand Yadav
- Department
of Chemistry, School of Basic Sciences, Central University of Haryana, Jant-Pali, Mahendergarh 123031, Haryana, India
| | - Priya Bhardwaj
- Department
of Biochemistry, School of Interdisciplinary and Applied Sciences, Central University of Haryana, Jant-Pali, Mahendergarh 123031, Haryana, India
| | - Mulaka Maruthi
- Department
of Biochemistry, School of Interdisciplinary and Applied Sciences, Central University of Haryana, Jant-Pali, Mahendergarh 123031, Haryana, India
| | - Anindita Chakraborty
- Department
of Chemistry, School of Basic Sciences, Central University of Haryana, Jant-Pali, Mahendergarh 123031, Haryana, India
| | - Prakash Kanoo
- Department
of Chemistry, School of Basic Sciences, Central University of Haryana, Jant-Pali, Mahendergarh 123031, Haryana, India
| |
Collapse
|
7
|
Sun Z, Li T, Mei T, Liu Y, Wu K, Le W, Hu Y. Nanoscale MOFs in nanomedicine applications: from drug delivery to therapeutic agents. J Mater Chem B 2023; 11:3273-3294. [PMID: 36928915 DOI: 10.1039/d3tb00027c] [Citation(s) in RCA: 15] [Impact Index Per Article: 15.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/06/2023]
Abstract
Metal-organic frameworks (MOFs) hold great promise for widespread applications in biomedicine and nanomedicine. MOFs are one of the most fascinating nanocarriers for drug delivery, benefiting from their high porosity and facile modification. Furthermore, the tailored components of MOFs can be therapeutic agents for various treatments, including drugs as organic ligands of MOFs, active metal as central metal ions of MOFs, and their combinations as carrier-free MOF-based nanodrug. In this review, the advances in delivery systems and applications as therapeutic agents for nanoscale MOF-based materials are summarized. The challenges of MOFs in clinical translation and the future directions in the field of MOFs therapy are also discussed. We hope that more researchers will focus their attention on advancing and translating MOF-based nanodrugs into pre-clinical and clinical applications.
Collapse
Affiliation(s)
- Zeyi Sun
- Institute for Regenerative Medicine, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200092, China. .,Shanghai East Hospital, Jinzhou Medical University, Jinzhou 121001, China
| | - Tieyan Li
- Department of Cardiovascular Surgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200092, China
| | - Tianxiao Mei
- Institute for Regenerative Medicine, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200092, China.
| | - Yang Liu
- Shanghai Heart Failure Research Center, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200092, China
| | - Kerui Wu
- Institute for Regenerative Medicine, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200092, China.
| | - Wenjun Le
- Institute for Regenerative Medicine, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200092, China.
| | - Yihui Hu
- Institute for Regenerative Medicine, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200092, China.
| |
Collapse
|
8
|
Zhou J, Guo M, Wu D, Shen M, Liu D, Ding T. Synthesis of UiO-66 loaded-caffeic acid and study of its antibacterial mechanism. Food Chem 2023; 402:134248. [DOI: 10.1016/j.foodchem.2022.134248] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2022] [Revised: 09/01/2022] [Accepted: 09/11/2022] [Indexed: 11/25/2022]
|
9
|
Le BQG, Doan TLH. Trend in biodegradable porous nanomaterials for anticancer drug delivery. WILEY INTERDISCIPLINARY REVIEWS. NANOMEDICINE AND NANOBIOTECHNOLOGY 2023:e1874. [PMID: 36597015 DOI: 10.1002/wnan.1874] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/26/2022] [Revised: 11/21/2022] [Accepted: 11/23/2022] [Indexed: 01/05/2023]
Abstract
In recent years, biodegradable nanomaterials have exhibited remarkable promise for drug administration to tumors due to their high drug-loading capacity, biocompatibility, biodegradability, and clearance. This review will discuss and summarize the trends in utilizing biodegradable nanomaterials for anticancer drug delivery, including biodegradable periodic mesoporous organosilicas (BPMOs) and metal-organic frameworks (MOFs). The distinct structure and features of BPMOs and MOFs will be initially evaluated, as well as their use as delivery vehicles for anticancer drug delivery applications. Then, the themes for the development of each material will be utilized to illustrate their drug delivery performance. Finally, the current obstacles and potential for future development as efficient drug delivery systems will be thoroughly reviewed. This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease.
Collapse
Affiliation(s)
- Bao Quang Gia Le
- Center for Innovative Materials and Architectures, Ho Chi Minh City, Vietnam.,Vietnam National University-Ho Chi Minh City, Ho Chi Minh City, Vietnam.,Department of Chemistry, University of Massachusetts Amherst, Amherst, Massachusetts, USA
| | - Tan Le Hoang Doan
- Center for Innovative Materials and Architectures, Ho Chi Minh City, Vietnam.,Vietnam National University-Ho Chi Minh City, Ho Chi Minh City, Vietnam
| |
Collapse
|
10
|
Larasati L, Lestari WW, Firdaus M. Dual-Action Pt(IV) Prodrugs and Targeted Delivery in Metal-Organic Frameworks: Overcoming Cisplatin Resistance and Improving Anticancer Activity. BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN 2022. [DOI: 10.1246/bcsj.20220218] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
- Larasati Larasati
- Master of Chemistry Program, Faculty of Mathematics and Natural Sciences, Universitas Sebelas Maret Surakarta, Jl. Ir. Sutami No. 36A, Kentingan Jebres, Surakarta, Central Java, Indonesia, 57126
| | - Witri Wahyu Lestari
- Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Sebelas Maret Surakarta, Jl. Ir. Sutami No. 36A, Kentingan Jebres, Surakarta, Central Java, Indonesia, 57126
| | - Maulidan Firdaus
- Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Sebelas Maret Surakarta, Jl. Ir. Sutami No. 36A, Kentingan Jebres, Surakarta, Central Java, Indonesia, 57126
| |
Collapse
|
11
|
Zeng Z, Shen H, Gao W, Guo Q, Chen M, Yan X, Liu H, Ji Y. A novel biocompatible Eu-based coordination polymers of cytarabine anticancer drug: Preparation, luminescence properties and in vitro anticancer activity studies. Front Chem 2022; 10:1043810. [DOI: 10.3389/fchem.2022.1043810] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2022] [Accepted: 10/21/2022] [Indexed: 11/13/2022] Open
Abstract
In this study, we use cytarabine anticancer drug to synthesize a new rare earth complex with Europium ion. The study work is an attempt to investigate luminescence and biological properties of the Eu-based coordination polymers of cytarabine (Eu-CP-Ara) anticancer drug which have been prepared by us. Eu-CP-Ara has luminescence properties with emission centering at about 619 nm excited with 394 nm. We study cytarabine and Eu-CP-Ara in vitro cytotoxicity. Cytotoxicity of Eu-CP-Ara against lung cancer cells (A549) could even be comparable to the inhibitory effect of cytarabine ligands, showing the advantage of antitumor activity. In addition, Eu-CP-Ara showed lower cytotoxicity to normal liver cells (L02). At the same, from the CLSM images, Eu-CP-Ara has successfully entered the A549 cell. Hence, Eu-CP-Ara can be used as a potential anticancer drug. Eu-CP-Ara may be an effective strategy for the tracking cytarabine against tumours and might impart better accurate treatment effect and therapeutic efficiency.
Collapse
|
12
|
Demir Duman F, Monaco A, Foulkes R, Becer CR, Forgan RS. Glycopolymer-Functionalized MOF-808 Nanoparticles as a Cancer-Targeted Dual Drug Delivery System for Carboplatin and Floxuridine. ACS APPLIED NANO MATERIALS 2022; 5:13862-13873. [PMID: 36338327 PMCID: PMC9623548 DOI: 10.1021/acsanm.2c01632] [Citation(s) in RCA: 11] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/05/2023]
Abstract
Codelivery of chemotherapeutics via nanomaterials has attracted much attention over the last decades due to improved drug delivery to tumor tissues, decreased systemic effects, and increased therapeutic efficacies. High porosities, large pore volumes and surface areas, and tunable structures have positioned metal-organic frameworks (MOFs) as promising drug delivery systems (DDSs). In particular, nanoscale Zr-linked MOFs such as MOF-808 offer notable advantages for biomedical applications such as high porosity, good stability, and biocompatibility. In this study, we report efficient dual drug delivery of floxuridine (FUDR) and carboplatin (CARB) loaded in MOF-808 nanoparticles to cancer cells. The nanoparticles were further functionalized by a poly(acrylic acid-mannose acrylamide) (PAAMAM) glycopolymer coating to obtain a highly selective DDS in cancer cells and enhance the therapeutic efficacy of chemotherapy. While MOF-808 was found to enhance the individual therapeutic effects of FUDR and CARB toward cancerous cells, combining FUDR and CARB was seen to cause a synergistic effect, further enhancing the cytotoxicity of the free drugs. Enhancement of CARB loading and therefore cytotoxicity of the CARB-loaded MOFs could be induced through a modified activation protocol, while coating of MOF-808 with the PAAMAM glycopolymer increased the uptake of the nanoparticles in cancer cells used in the study and offered a particularly significant selective drug delivery with high cytotoxicity in HepG2 human hepatocellular carcinoma cells. These results show how the enhancement of cytotoxicity is possible through both nanovector delivery and synergistic treatment, and that MOF-808 is a viable candidate for future drug delivery studies.
Collapse
Affiliation(s)
- Fatma Demir Duman
- WestCHEM,
School of Chemistry, University of Glasgow,
University Avenue, Glasgow G12 8QQ, U.K.
| | - Alessandra Monaco
- Department
of Chemistry, University of Warwick, CV4 7AL Coventry, U.K.
| | - Rachel Foulkes
- WestCHEM,
School of Chemistry, University of Glasgow,
University Avenue, Glasgow G12 8QQ, U.K.
| | - C. Remzi Becer
- Department
of Chemistry, University of Warwick, CV4 7AL Coventry, U.K.
| | - Ross S. Forgan
- WestCHEM,
School of Chemistry, University of Glasgow,
University Avenue, Glasgow G12 8QQ, U.K.
- E-mail:
| |
Collapse
|
13
|
Metal-organic framework-based smart nanoplatforms with multifunctional attributes for biosensing, drug delivery, and cancer theranostics. INORG CHEM COMMUN 2022. [DOI: 10.1016/j.inoche.2022.110145] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
14
|
Parsaei M, Akhbari K. Smart Multifunctional UiO-66 Metal-Organic Framework Nanoparticles with Outstanding Drug-Loading/Release Potential for the Targeted Delivery of Quercetin. Inorg Chem 2022; 61:14528-14543. [PMID: 36074039 DOI: 10.1021/acs.inorgchem.2c00743] [Citation(s) in RCA: 15] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
Herein, UiO-66 and its two functional analogs (with -NO2 and -NH2 functional groups) were synthesized, and their potential ability as pH stimulus nanocarriers of quercetin (QU), an anticancer agent, was studied. UiO-66 is a low-toxicity, biocompatible metal-organic framework with a large surface area and good stability, which can be prepared through a facile and inexpensive method. Before and after drug loading, various analyses were conducted to characterize the synthesized nanocarriers. Moreover, Monte Carlo simulations were performed to investigate their structures and interactions with quercetin. The most promising drug loading potential and prolonged drug release (over 25 days) were observed in QU@UiO-66-NO2 with 37% drug loading content, which was the best-tested sample that exhibited a higher release rate under acidic conditions (pH = 5) than that in normal cells (pH = 7.4). This behavior is known as pH-stimulus-controlled ability. The cell treatment with free QU, UiO-66-R, and QU@UiO-66-R (R = -H, -NO2, and -NH2) was performed, and an MTT assay was conducted on HEK-293 and MDA-MB-231 cells for the cytotoxicity study. Additionally, the kinetic modeling of drug release was investigated on the basis of the analysis of the drug release profiles.
Collapse
Affiliation(s)
- Mozhgan Parsaei
- School of Chemistry, College of Science, University of Tehran, 14155-6455 Tehran, Iran
| | - Kamran Akhbari
- School of Chemistry, College of Science, University of Tehran, 14155-6455 Tehran, Iran
| |
Collapse
|
15
|
Rezaee T, Fazel-Zarandi R, Karimi A, Ensafi AA. Metal-organic frameworks for pharmaceutical and biomedical applications. J Pharm Biomed Anal 2022; 221:115026. [PMID: 36113325 DOI: 10.1016/j.jpba.2022.115026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2022] [Revised: 08/28/2022] [Accepted: 08/30/2022] [Indexed: 10/31/2022]
Abstract
Metal-organic framework (MOF) materials provide unprecedented opportunities for evaluating valuable compounds for various medical applications. MOFs merged with biomolecules, used as novel biomaterials, have become particularly useful in biological environments. Bio-MOFs can be promising materials in the global to avoid utilization above toxicological substances. Bio-MOFs with crystallin and porosity nature offer flexible structure via bio-linker and metal node variation, which improves their wide applicability in medical science.
Collapse
Affiliation(s)
- Tooba Rezaee
- Department of Chemistry, Isfahan University of Technology, Isfahan 84156-83111, Iran
| | | | - Afsaneh Karimi
- Department of Chemistry, Isfahan University of Technology, Isfahan 84156-83111, Iran
| | - Ali A Ensafi
- Department of Chemistry, Isfahan University of Technology, Isfahan 84156-83111, Iran; Adjunct Professor, Department of Chemistry & Biochemistry, University of Arkansas, Fayetteville, AR 72701, USA.
| |
Collapse
|
16
|
Pourmadadi M, Eshaghi MM, Ostovar S, Shamsabadipour A, Safakhah S, Mousavi MS, Rahdar A, Pandey S. UiO-66 metal-organic framework nanoparticles as gifted MOFs to the biomedical application: A comprehensive review. J Drug Deliv Sci Technol 2022. [DOI: 10.1016/j.jddst.2022.103758] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
17
|
Linnane E, Haddad S, Melle F, Mei Z, Fairen-Jimenez D. The uptake of metal-organic frameworks: a journey into the cell. Chem Soc Rev 2022; 51:6065-6086. [PMID: 35770998 PMCID: PMC9289890 DOI: 10.1039/d0cs01414a] [Citation(s) in RCA: 26] [Impact Index Per Article: 13.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2022] [Indexed: 12/25/2022]
Abstract
The application of metal-organic frameworks (MOFs) in drug delivery has advanced rapidly over the past decade, showing huge progress in the development of novel systems. Although a large number of versatile MOFs that can carry and release multiple compounds have been designed and tested, one of the main limitations to their translation to the clinic is the limited biological understanding of their interaction with cells and the way they penetrate them. This is a crucial aspect of drug delivery, as MOFs need to be able not only to enter into cells but also to release their cargo in the correct intracellular location. While small molecules can enter cells by passive diffusion, nanoparticles (NPs) usually require an energy-dependent process known as endocytosis. Importantly, the fate of NPs after being taken up by cells is dependent on the endocytic pathways they enter through. However, no general guidelines for MOF particle internalization have been established due to the inherent complexity of endocytosis as a mechanism, with several factors affecting cellular uptake, namely NP size and surface chemistry. In this review, we cover recent advances regarding the understanding of the mechanisms of uptake of nano-sized MOFs (nanoMOFs)s, their journey inside the cell, and the importance of biological context in their final fate. We examine critically the impact of MOF physicochemical properties on intracellular trafficking and successful cargo delivery. Finally, we highlight key unanswered questions on the topic and discuss the future of the field and the next steps for nanoMOFs as drug delivery systems.
Collapse
Affiliation(s)
- Emily Linnane
- The Adsorption & Advanced Materials Laboratory (A2ML), Department of Chemical Engineering and Biotechnology, University of Cambridge, Phillipa Fawcett Drive, CB3 0AS, UK.
| | - Salame Haddad
- The Adsorption & Advanced Materials Laboratory (A2ML), Department of Chemical Engineering and Biotechnology, University of Cambridge, Phillipa Fawcett Drive, CB3 0AS, UK.
| | - Francesca Melle
- The Adsorption & Advanced Materials Laboratory (A2ML), Department of Chemical Engineering and Biotechnology, University of Cambridge, Phillipa Fawcett Drive, CB3 0AS, UK.
| | - Zihan Mei
- The Adsorption & Advanced Materials Laboratory (A2ML), Department of Chemical Engineering and Biotechnology, University of Cambridge, Phillipa Fawcett Drive, CB3 0AS, UK.
| | - David Fairen-Jimenez
- The Adsorption & Advanced Materials Laboratory (A2ML), Department of Chemical Engineering and Biotechnology, University of Cambridge, Phillipa Fawcett Drive, CB3 0AS, UK.
| |
Collapse
|
18
|
Engineering Bio-MOF/polydopamine as a biocompatible targeted theranostic system for synergistic multi-drug chemo-photothermal therapy. Int J Pharm 2022; 623:121912. [PMID: 35710074 DOI: 10.1016/j.ijpharm.2022.121912] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2022] [Revised: 05/12/2022] [Accepted: 06/09/2022] [Indexed: 11/21/2022]
Abstract
In this study, a biodegradable multifunctional photothermal drug delivery nanoparticles (MPH NPs) using curcumin (Cur) as the ligand coated with hyaluronic acid (HA) was successfully prepared, which could simultaneously deliver Cur and doxorubicin hydrochloride (DOX·HCl) to overcome the common drug resistance in cancer cells. Polydopamine (PDA) as a protective shell prevents premature degradation of Cur in physiological environment and enables it to play effective medicinal value. MPH NPs can specifically recognize CD44 receptors on the surface of cancer cells for tumor targeting, with the damage of the partially released DOX to the superficial tumor cells, and then the positively charged Cur released may gradually penetrate into the cells through electron interaction to improve the problem of low permeability. In vitro cell experiments showed that hydrophobic/hydrophilic drugs co-loaded MPDH (MPH loaded with DOX·HCl) could enter the cancer cells through the endocytosis mediated by clathrin / caveolin, and the inhibition rate of MPDH on HeLa cells reached 79.28 % irradiation under 808 nm laser. MPH were composed of safe materials that have been proven to be biodegradable in human body, which avoided the disadvantages that NPs were difficult to discharge and caused damage to normal organs during long-term use.
Collapse
|
19
|
Ceballos M, Cedrún-Morales M, Rodríguez-Pérez M, Funes-Hernando S, Vila-Fungueiriño JM, Zampini G, Navarro Poupard MF, Polo E, Del Pino P, Pelaz B. High-yield halide-assisted synthesis of metal-organic framework UiO-based nanocarriers. NANOSCALE 2022; 14:6789-6801. [PMID: 35467684 PMCID: PMC9109712 DOI: 10.1039/d1nr08305h] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 12/17/2021] [Accepted: 03/15/2022] [Indexed: 06/14/2023]
Abstract
The synthesis of nanosized metal-organic frameworks (NMOFs) is requisite for their application as injectable drug delivery systems (DDSs) and other biorelevant purposes. Herein, we have critically examined the role of different synthetic parameters leading to the production of UiO-66 crystals smaller than 100 nm. Of note, we demonstrate the co-modulator role conferred by halide ions, not only to produce NMOFs with precise morphology and size, but also to significantly improve the reaction yield. The resulting NMOFs are highly crystalline and exhibit sustained colloidal stability in different biologically relevant media. As a proof of concept, these NMOFs were loaded with Rhodamine 6G (R6G), which remained trapped in most common biologically relevant media. When incubated with living mammalian cells, the R6G-loaded NMOFs were efficiently internalized and did not impair cell viability even at relatively high doses.
Collapse
Affiliation(s)
- Manuel Ceballos
- Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CiQUS), Departamento de Física de Partículas, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
| | - Manuela Cedrún-Morales
- Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CiQUS), Departamento de Física de Partículas, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
| | - Manuel Rodríguez-Pérez
- Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CiQUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
| | - Samuel Funes-Hernando
- Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CiQUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
| | - José Manuel Vila-Fungueiriño
- Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CiQUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
| | - Giulia Zampini
- Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CiQUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
| | - Maria F Navarro Poupard
- Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CiQUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
| | - Ester Polo
- Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CiQUS), Departamento de Bioquímica, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
| | - Pablo Del Pino
- Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CiQUS), Departamento de Física de Partículas, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
| | - Beatriz Pelaz
- Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CiQUS), Departamento de Química Inorgánica, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
| |
Collapse
|
20
|
Li Q, Liu Y, Zhang Y, Jiang W. Immunogenicity-boosted cancer immunotherapy based on nanoscale metal-organic frameworks. J Control Release 2022; 347:183-198. [PMID: 35526612 DOI: 10.1016/j.jconrel.2022.05.003] [Citation(s) in RCA: 15] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2022] [Revised: 04/29/2022] [Accepted: 05/02/2022] [Indexed: 12/22/2022]
Abstract
Immunotherapy, including checkpoint blockade immunotherapy (CBI), has witnessed remarkable progress in cancer therapy. Nonetheless, significant obstacles to successful immunotherapy remain. Notably, tumour non-responsiveness to immunotherapy due to immunosuppressive tumour microenvironments (TMEs). To revitalize immunosuppressive TMEs various therapeutic strategies have been reported by researchers. Immunostimulatory adjuvant treatments (IAT) are the most widely investigated ones. Due to their biodegradability, compositional tenability, and inherent immune effectiveness, nanoscale metal-organic frameworks (nMOFs) with metal nodes and organic linkers can be used as versatile nanomaterials for IAT. This review summarizes the progress in nMOF-based tumour immunotherapy in promoting immunostimulatory TMEs. And in combination with other cancer immunotherapies to increase tumour immunogenicity and antitumor efficacy. Finally, the challenges of nMOFs in tumour immunotherapy are also discussed.
Collapse
Affiliation(s)
- Qing Li
- Department of Molecular Pathology, Application Center for Precision Medicine, the Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China
| | - Ying Liu
- Department of Molecular Pathology, Application Center for Precision Medicine, the Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China
| | - Yanru Zhang
- Department of Molecular Pathology, Application Center for Precision Medicine, the Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China
| | - Wei Jiang
- Department of Molecular Pathology, Application Center for Precision Medicine, the Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China.
| |
Collapse
|
21
|
Dai Z, Wang Q, Tang J, Qu R, Wu M, Li H, Yang Y, Zhen X, Yu C. A Sub-6 nm MnFe2O4-dichloroacetic acid nanocomposite modulates tumor metabolism and catabolism for reversing tumor immunosuppressive microenvironment and boosting immunotherapy. Biomaterials 2022; 284:121533. [DOI: 10.1016/j.biomaterials.2022.121533] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2021] [Revised: 03/31/2022] [Accepted: 04/15/2022] [Indexed: 12/19/2022]
|
22
|
|
23
|
Al-Azawi A, Sulaiman S, Arafat K, Yasin J, Nemmar A, Attoub S. Impact of Sodium Dichloroacetate Alone and in Combination Therapies on Lung Tumor Growth and Metastasis. Int J Mol Sci 2021; 22:ijms222212553. [PMID: 34830434 PMCID: PMC8624089 DOI: 10.3390/ijms222212553] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2021] [Revised: 11/14/2021] [Accepted: 11/17/2021] [Indexed: 01/07/2023] Open
Abstract
Metabolic reprogramming has been recognized as an essential emerging cancer hallmark. Dichloroacetate (DCA), an inhibitor of pyruvate dehydrogenase kinase (PDK), has been reported to have anti-cancer effects by reversing tumor-associated glycolysis. This study was performed to explore the anti-cancer potential of DCA in lung cancer alone and in combination with chemo- and targeted therapies using two non-small cell lung cancer (NSCLC) cell lines, namely, A549 and LNM35. DCA markedly caused a concentration- and time-dependent decrease in the viability and colony growth of A549 and LNM35 cells in vitro. DCA also reduced the growth of tumor xenografts in both a chick embryo chorioallantoic membrane and nude mice models in vivo. Furthermore, DCA decreased the angiogenic capacity of human umbilical vein endothelial cells in vitro. On the other hand, DCA did not inhibit the in vitro cellular migration and invasion and the in vivo incidence and growth of axillary lymph nodes metastases in nude mice. Treatment with DCA did not show any toxicity in chick embryos and nude mice. Finally, we demonstrated that DCA significantly enhanced the anti-cancer effect of cisplatin in LNM35. In addition, the combination of DCA with gefitinib or erlotinib leads to additive effects on the inhibition of LNM35 colony growth after seven days of treatment and to synergistic effects on the inhibition of A549 colony growth after 14 days of treatment. Collectively, this study demonstrates that DCA is a safe and promising therapeutic agent for lung cancer.
Collapse
Affiliation(s)
- Aya Al-Azawi
- Department of Pharmacology & Therapeutics, College of Medicine & Health Sciences, United Arab Emirates University, Al-Ain 17666, United Arab Emirates; (A.A.-A.); (S.S.); (K.A.)
| | - Shahrazad Sulaiman
- Department of Pharmacology & Therapeutics, College of Medicine & Health Sciences, United Arab Emirates University, Al-Ain 17666, United Arab Emirates; (A.A.-A.); (S.S.); (K.A.)
| | - Kholoud Arafat
- Department of Pharmacology & Therapeutics, College of Medicine & Health Sciences, United Arab Emirates University, Al-Ain 17666, United Arab Emirates; (A.A.-A.); (S.S.); (K.A.)
| | - Javed Yasin
- Department of Medicine, College of Medicine & Health Sciences, United Arab Emirates University, Al-Ain 17666, United Arab Emirates;
| | - Abderrahim Nemmar
- Department of Physiology, College of Medicine & Health Sciences, United Arab Emirates University, Al-Ain 17666, United Arab Emirates;
- Zayed Center for Health Sciences, United Arab Emirates University, Al-Ain 17666, United Arab Emirates
| | - Samir Attoub
- Department of Pharmacology & Therapeutics, College of Medicine & Health Sciences, United Arab Emirates University, Al-Ain 17666, United Arab Emirates; (A.A.-A.); (S.S.); (K.A.)
- Zayed Center for Health Sciences, United Arab Emirates University, Al-Ain 17666, United Arab Emirates
- Institut National de la Santé et de la Recherche Médicale (INSERM), 75013 Paris, France
- Correspondence:
| |
Collapse
|
24
|
Application of smart nanoparticles as a potential platform for effective colorectal cancer therapy. Coord Chem Rev 2021. [DOI: 10.1016/j.ccr.2021.213949] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
|
25
|
Hashemzadeh A, Drummen GPC, Avan A, Darroudi M, Khazaei M, Khajavian R, Rangrazi A, Mirzaei M. When metal-organic framework mediated smart drug delivery meets gastrointestinal cancers. J Mater Chem B 2021; 9:3967-3982. [PMID: 33908592 DOI: 10.1039/d1tb00155h] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Cancers of the gastrointestinal tract constitute one of the most common cancer types worldwide and a ∼58% increase in the global number of cases has been estimated by IARC for the next twenty years. Recent advances in drug delivery technologies have attracted scientific interest for developing and utilizing efficient therapeutic systems. The present review focuses on the use of nanoscale MOFs (Nano-MOFs) as carriers for drug delivery and imaging purposes. In pursuit of significant improvements to current gastrointestinal cancer chemotherapy regimens, systems that allow multiple concomitant therapeutic options (polytherapy) and controlled release are highly desirable. In this sense, MOF-based nanotherapeutics represent a significant step towards achieving this goal. Here, the current state-of-the-art of interdisciplinary research and novel developments into MOF-based gastrointestinal cancer therapy are highlighted and reviewed.
Collapse
Affiliation(s)
- Alireza Hashemzadeh
- Department of Medical Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
| | - Gregor P C Drummen
- (Bio)Nanotechnology and Hepato/Renal Pathobiology Programs, Bio&Nano Solutions-LAB3BIO, Bielefeld, Germany
| | - Amir Avan
- Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Majid Darroudi
- Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
| | - Majid Khazaei
- Department of Medical Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. and Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Ruhollah Khajavian
- Department of Chemistry, Faculty of Science, Ferdowsi University of Mashhad, Mashhad 9177948974, Iran.
| | | | - Masoud Mirzaei
- Department of Chemistry, Faculty of Science, Ferdowsi University of Mashhad, Mashhad 9177948974, Iran.
| |
Collapse
|
26
|
Lázaro IA, Popescu C, Cirujano FG. Controlling the molecular diffusion in MOFs with the acidity of monocarboxylate modulators. Dalton Trans 2021; 50:11291-11299. [PMID: 34342329 DOI: 10.1039/d1dt01773j] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The catalytic performance of metal-organic frameworks (MOFs) is related to their physicochemical properties, such as particle size, defect chemistry and porosity, which can be potentially controlled by coordination modulation. By combining PXRD, 1HNMR, FT-IR, and N2 uptake measurements we have gained insights into the control of different types of defects (missing linker or missing cluster consequence of the spatial distribution of missing linkers, and a combination of both) by the type of modulator employed. We show that the molar percent of defects, either as missing linkers or as a part of missing cluster defects, is related to the acidity of a modulator and its subsequent incorporation into the UiO-66 structure. Modulators with strong acidity and small size result in a considerable defect induction that causes an increase in the external surface area and mesopore volume, which is beneficial for the ring-opening of epoxides with amines, using UiO-66 defect-modulated MOFs as heterogeneous catalysts.
Collapse
Affiliation(s)
- Isabel Abánades Lázaro
- Instituto de Ciencia Molecular (ICMol), Universitat de València, Catedrático José Beltrán Martínez no 2, 46980 Paterna, Valencia, Spain.
| | | | | |
Collapse
|
27
|
Zheng Y, Zhang X, Su Z. Design of metal-organic framework composites in anti-cancer therapies. NANOSCALE 2021; 13:12102-12118. [PMID: 34236380 DOI: 10.1039/d1nr02581c] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
Metal-organic frameworks are a class of new and promising anti-cancer materials. MOFs with adjustable pore size, large specific surface area, diverse structure, and excellent chemical and physical properties make them a class of effective protection carriers for anti-cancer substances. This review is centered on the core point of "anti-cancer" and discusses MOFs' research progress in anti-cancer therapies. Firstly, we provided readers with the different types of MOFs, their preparation strategies and the resulting structures. Then, different MOF composites and their biological applications were systematically presented. The specificity of biomolecules endows MOFs with broader anti-cancer applications, while MOFs can protect the drugs and biomolecules to make the best of a challenging situation. Finally, we elucidated a comprehensive overview of the biological applications of MOFs, including research hotspots as drug delivery and biomolecule carriers. Besides, we looked forward to the future developments of MOFs in the field of anti-cancer therapies. As a class of novel materials, the anti-cancer applications of MOFs are extended through the combination of different materials and different methods to improve their efficacy.
Collapse
Affiliation(s)
- Yadan Zheng
- State Key Laboratory of Chemical Resource Engineering, Beijing Key Laboratory of Advanced Functional Polymer Composites, Beijing University of Chemical Technology, 100029 Beijing, China.
| | | | | |
Collapse
|
28
|
Lázaro IA, Rodrigo-Muñoz JM, Sastre B, Ángel MR, Martí-Gastaldo C, Del Pozo V. The excellent biocompatibility and negligible immune response of the titanium heterometallic MOF MUV-10. J Mater Chem B 2021; 9:6144-6148. [PMID: 34286816 DOI: 10.1039/d1tb00981h] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The Ti-Ca heterometallic MOF MUV-10 exhibits good dispersibility in phosphate buffer and low phosphate-induced degradation in comparison to other MOF systems. It induces no cytotoxicity towards cells of the immune system and no inmune response, making it an attractive candidate for biomedical applications and demonstrating its safe use for other applications.
Collapse
Affiliation(s)
- Isabel Abánades Lázaro
- Instituto de Ciencia Molecular (ICMol), Universitat de València, Catedrático José Beltrán Martínez no. 2, Paterna 46980, Valencia, Spain.
| | | | | | | | | | | |
Collapse
|
29
|
Delivery of oxaliplatin to colorectal cancer cells by folate-targeted UiO-66-NH 2. Toxicol Appl Pharmacol 2021; 423:115573. [PMID: 33991535 DOI: 10.1016/j.taap.2021.115573] [Citation(s) in RCA: 22] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/02/2021] [Revised: 03/21/2021] [Accepted: 05/10/2021] [Indexed: 12/11/2022]
Abstract
Oxaliplatin is being used in different malignancies and several side effects are reported for patients taking Oxaliplatin, including peripheral neuropathy, nausea and vomiting, diarrhea, mouth sores, low blood counts, fatigue, loss of appetite, etc. Here we have developed a targeted anticancer drug delivery system based on folate-conjugated amine-functionalized UiO-66 for the delivery of oxaliplatin (OX). UiO-66-NH2 (U) and UiO-66-NH2-FA(FU) were pre-functionalized by the incorporation of folic acid (FA) into the structure via coordination of the carboxylate group of FA. The FTIR spectra of drug-loaded U and FU showed the presence of new carboxylic and aliphatic groups of OX and FA. Powder X-ray diffraction (PXRD) patterns were matched accordingly with the reference pattern and FESEM results showed semi-spherical particles (115-128 nm). The evaluated amounts of OX in U and FU were calculated 304.5 and 293 mg/g, respectively. The initial burst release of OX was 15.7% per hour for U(OX) and 10.8% per hour for FU(OX). The final release plateau gives 62.9% and 52.3% for U(OX) and FU(OX). To evaluate the application of the prepared delivery platform, they were tested on colorectal cancer cells (CT-26) via MTT assay, cell migration assay, and spheroid model. IC50 values obtained from MTT assay were 21.38, 95.50, and 18.20 μg/mL for OX, U(OX), and FU(OX), respectively. After three days of treatment, the CT26 spheroids at two doses of 500 and 50 μg/mL of U(OX) and FU(OX) showed volume reduction. Moreover, the oxidative behavior of the prepared systems within the cell was assessed by total thiol, malondialdehyde, and superoxide dismutase activity. The results showed that FU(OX) had higher efficacy in preventing the growth of CT-26 spheroid, and was more effective than oxaliplation in cell migration inhibition, and induced higher oxidative stress and apoptosis.
Collapse
|
30
|
Harvey PD, Plé J. Recent Advances in Nanoscale Metal-Organic Frameworks Towards Cancer Cell Cytotoxicity: An Overview. J Inorg Organomet Polym Mater 2021; 31:2715-2756. [PMID: 33994899 PMCID: PMC8114195 DOI: 10.1007/s10904-021-02011-3] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2021] [Accepted: 04/19/2021] [Indexed: 02/03/2023]
Abstract
Abstract The fight against cancer has always been a prevalent research topic. Nanomaterials have the ability to directly penetrate cancer cells and potentially achieve minimally invasive, precise and efficient tumor annihilation. As such, nanoscale metal organic frameworks (nMOFs) are becoming increasingly attractive as potential therapeutic agents in the medical field due to their high structural variability, good biocompatibility, ease of surface functionalization as well as their porous morphologies with tunable cavity sizes. This overview addresses five different common strategies used to find cancer therapies, while summarizing the recent progress in using nMOFs as cytotoxic cancer cell agents largely through in vitro studies, although some in vivo investigations have also been reported. Chemo and targeted therapies rely on drug encapsulation and delivery inside the cell, whereas photothermal and photodynamic therapies depend on photosensitizers. Concurrently, immunotherapy actively induces the body to destroy the tumor by activating an immune response. By choosing the appropriate metal center, ligands and surface functionalization, nMOFs can be utilized in all five types of therapies. In the last section, the future prospects and challenges of nMOFs with respect to the various therapies will be presented and discussed. Graphic Abstract
Collapse
Affiliation(s)
- Pierre D. Harvey
- Département de Chimie, Université de Sherbrooke, Sherbrooke, PQ J1K 2R1 Canada
| | - Jessica Plé
- Département de Chimie, Université de Sherbrooke, Sherbrooke, PQ J1K 2R1 Canada
| |
Collapse
|
31
|
Wang Y, Wang F, Chen Z, Song M, Yao X, Jiang G. In situ High-Throughput Single-Cell Analysis Reveals the Crosstalk between Nanoparticle-Induced Cell Responses. ENVIRONMENTAL SCIENCE & TECHNOLOGY 2021; 55:5136-5142. [PMID: 33760593 DOI: 10.1021/acs.est.0c08424] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
Nanomaterials are widely used in a variety of industrial, biological, and medical applications. Therefore, high concerns about their possible impact on human and environmental health have been raised. Here, we describe a high-throughput single-cell imaging method to reveal the crosstalk among quantum dot (QDot)-induced ROS generation, apoptosis, and changes in nucleus size in macrophages. In triple marker combinations, we assessed the correlations of three QDot-induced cellular responses via divided subsets based on single-cell analysis. In contrast to the results obtained from the cell population, we demonstrated that the change in nucleus size was positively correlated with ROS generation. We found that QDot exposure induced ROS generation, which led to cell apoptosis, followed by a change in nucleus size. In general, these observations on crosstalk of cellular responses provide detailed insights into the heterogeneity of nanoparticle exposure.
Collapse
Affiliation(s)
- Yuanyuan Wang
- Key Laboratory of Environmental Nanotechnology and Health Effects, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China
- University of Chinese Academy of Sciences, Beijing 100049, China
| | - Fengbang Wang
- Key Laboratory of Environmental Nanotechnology and Health Effects, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China
- University of Chinese Academy of Sciences, Beijing 100049, China
| | - Zihan Chen
- Key Laboratory of Environmental Nanotechnology and Health Effects, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China
- University of Chinese Academy of Sciences, Beijing 100049, China
| | - Maoyong Song
- Key Laboratory of Environmental Nanotechnology and Health Effects, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China
- State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China
- University of Chinese Academy of Sciences, Beijing 100049, China
| | - Xinglei Yao
- Key Laboratory of Environmental Nanotechnology and Health Effects, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China
| | - Guibin Jiang
- State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China
- University of Chinese Academy of Sciences, Beijing 100049, China
| |
Collapse
|
32
|
Butova VV, Burachevskaya OA, Muratidi MA, Surzhikova II, Zolotukhin PV, Medvedev PV, Gorban IE, Kuzharov AA, Soldatov MA. Loading of the Model Amino Acid Leucine in UiO-66 and UiO-66-NH 2: Optimization of Metal-Organic Framework Carriers and Evaluation of Host-Guest Interactions. Inorg Chem 2021; 60:5694-5703. [PMID: 33830750 DOI: 10.1021/acs.inorgchem.0c03751] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Two metal-organic frameworks (MOFs), UiO-66 and UiO-66-NH2, were considered as containers for bioactive chemicals. We provide a synthesis technique, which allowed the production of these materials suitable for biomedical applications. Both MOFs were characterized as single-phase porous materials composed of nanoparticles (30-65 nm) with a ζ-potential of more than 40 mV in water suspension. D,L-Leucine was applied as a model molecule, which allowed us to trace the mechanism of the loading process. We showed that after synthesis, amino groups of UiO-66-NH2 are coordinated with solvent residuals. It results in a similar route of leucine loading in UiO-66 and UiO-66-NH2 samples. Using joint data of thermogravimetric analysis and calorimetry, infrared spectroscopy, and nitrogen adsorption, we revealed that methyl groups of leucine molecules are responsible for bonding of an MOF matrix. We proposed the formation of bonds between CH3 groups and benzene rings of linkers via CH-π interaction. We also assessed the toxicity of the synthesized MOFs toward HeLa cells at 50 μg/mL after 24 h incubation and revealed no negative effects on the viability of the cells, prompting further biomedical research in the areas of small-molecule delivery and cell signaling and metabolism modulation.
Collapse
Affiliation(s)
- Vera V Butova
- The Smart Materials Research Institute, Southern Federal University, 5 Zorge Street, Rostov-on-Don 344090, Russian Federation
| | - Olga A Burachevskaya
- The Smart Materials Research Institute, Southern Federal University, 5 Zorge Street, Rostov-on-Don 344090, Russian Federation
| | - Maria A Muratidi
- The Smart Materials Research Institute, Southern Federal University, 5 Zorge Street, Rostov-on-Don 344090, Russian Federation
| | - Iana I Surzhikova
- Institute of Physical and Organic Chemistry, Southern Federal University, 194/2 prosp. Stachki, Rostov-on-Don 344090, Russian Federation
| | - Peter V Zolotukhin
- The Smart Materials Research Institute, Southern Federal University, 5 Zorge Street, Rostov-on-Don 344090, Russian Federation
| | - Pavel V Medvedev
- The Smart Materials Research Institute, Southern Federal University, 5 Zorge Street, Rostov-on-Don 344090, Russian Federation
| | - Ivan E Gorban
- The Smart Materials Research Institute, Southern Federal University, 5 Zorge Street, Rostov-on-Don 344090, Russian Federation
| | - Andrey A Kuzharov
- The Smart Materials Research Institute, Southern Federal University, 5 Zorge Street, Rostov-on-Don 344090, Russian Federation
| | - Mikhail A Soldatov
- The Smart Materials Research Institute, Southern Federal University, 5 Zorge Street, Rostov-on-Don 344090, Russian Federation
| |
Collapse
|
33
|
Nalaparaju A, Jiang J. Metal-Organic Frameworks for Liquid Phase Applications. ADVANCED SCIENCE (WEINHEIM, BADEN-WURTTEMBERG, GERMANY) 2021; 8:2003143. [PMID: 33717851 PMCID: PMC7927635 DOI: 10.1002/advs.202003143] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/17/2020] [Revised: 10/19/2020] [Indexed: 05/10/2023]
Abstract
In the last two decades, metal-organic frameworks (MOFs) have attracted overwhelming attention. With readily tunable structures and functionalities, MOFs offer an unprecedentedly vast degree of design flexibility from enormous number of inorganic and organic building blocks or via postsynthetic modification to produce functional nanoporous materials. A large extent of experimental and computational studies of MOFs have been focused on gas phase applications, particularly the storage of low-carbon footprint energy carriers and the separation of CO2-containing gas mixtures. With progressive success in the synthesis of water- and solvent-resistant MOFs over the past several years, the increasingly active exploration of MOFs has been witnessed for widespread liquid phase applications such as liquid fuel purification, aromatics separation, water treatment, solvent recovery, chemical sensing, chiral separation, drug delivery, biomolecule encapsulation and separation. At this juncture, the recent experimental and computational studies are summarized herein for these multifaceted liquid phase applications to demonstrate the rapid advance in this burgeoning field. The challenges and opportunities moving from laboratory scale towards practical applications are discussed.
Collapse
Affiliation(s)
- Anjaiah Nalaparaju
- Department of Chemical and Biomolecular EngineeringNational University of SingaporeSingapore117576Singapore
| | - Jianwen Jiang
- Department of Chemical and Biomolecular EngineeringNational University of SingaporeSingapore117576Singapore
| |
Collapse
|
34
|
Song C, Zhang X, Wei W, Ma G. Principles of regulating particle multiscale structures for controlling particle-cell interaction process. Chem Eng Sci 2021. [DOI: 10.1016/j.ces.2020.116343] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
35
|
Lawson HD, Walton SP, Chan C. Metal-Organic Frameworks for Drug Delivery: A Design Perspective. ACS APPLIED MATERIALS & INTERFACES 2021; 13:7004-7020. [PMID: 33554591 DOI: 10.1021/acsami.1c01089] [Citation(s) in RCA: 242] [Impact Index Per Article: 80.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
The use of metal-organic frameworks (MOFs) in biomedical applications has greatly expanded over the past decade due to the precision tunability, high surface areas, and high loading capacities of MOFs. Specifically, MOFs are being explored for a wide variety of drug delivery applications. Initially, MOFs were used for delivery of small-molecule pharmaceuticals; however, more recent work has focused on macromolecular cargos, such as proteins and nucleic acids. Here, we review the historical application of MOFs for drug delivery, with a specific focus on the available options for designing MOFs for specific drug delivery applications. These options include choices of MOF structure, synthetic method, and drug loading. Further considerations include tuning, modifications, biocompatibility, cellular targeting, and uptake. Altogether, this Review aims to guide MOF design for novel biomedical applications.
Collapse
Affiliation(s)
- Harrison D Lawson
- Michigan State University, Department of Chemical Engineering and Materials Science, 428 South Shaw Lane, East Lansing, Michigan 48824, United States
| | - S Patrick Walton
- Michigan State University, Department of Chemical Engineering and Materials Science, 428 South Shaw Lane, East Lansing, Michigan 48824, United States
| | - Christina Chan
- Michigan State University, Department of Chemical Engineering and Materials Science, 428 South Shaw Lane, East Lansing, Michigan 48824, United States
- Michigan State University, Department of Biochemistry and Molecular Biology, 603 Wilson Road, East Lansing, Michigan 48824, United States
| |
Collapse
|
36
|
de Lima HHC, da Silva CTP, Kupfer VL, de C Rinaldi J, Kioshima ES, Mandelli D, Guilherme MR, Rinaldi AW. Synthesis of resilient hybrid hydrogels using UiO-66 MOFs and alginate (hydroMOFs) and their effect on mechanical and matter transport properties. Carbohydr Polym 2021; 251:116977. [PMID: 33142554 DOI: 10.1016/j.carbpol.2020.116977] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2020] [Revised: 08/19/2020] [Accepted: 08/20/2020] [Indexed: 11/28/2022]
Abstract
Herein, we report the preparation of an organic-inorganic hybrid hydrogel architecture using vinyl alginate and UiO-66 MOFs (metal-organic frameworks) modified with acrylic acid (AA) UiO-66AA. UiO-66 MOFs with different crystal sizes (600, 1500, and 2500 nm) were synthesized and the effect on the mechanical and transport properties of the resulting materials, such as water absorption capacity and drug release, were evaluated. HydroMOF showed higher water absorption capacity than the pure hydrogel and enhanced mechanical properties, which depend on crystal size and the amount of UiO-66AA MOF used. The initial release rate of drug (burst release) from hydroMOFs was lower when small-sized crystals or a small amount of large-sized crystals were used; thus these are essential in changing half-life values of release rates. Finally, the cytotoxicity screening successfully showed that hydroMOFs are promising biocompatible compounds proven to have the advantages of minimized burst release and mechanical robustness.
Collapse
Affiliation(s)
- Hugo H C de Lima
- Rinaldi Research Group, Department of Chemistry, State University of Maringá - UEM, 5790 Colombo Avenue, 87020-900, Maringá, PR, Brazil
| | - Cleiser T P da Silva
- Rinaldi Research Group, Department of Chemistry, State University of Maringá - UEM, 5790 Colombo Avenue, 87020-900, Maringá, PR, Brazil; Center of Natural and Human Sciences, Federal University of ABC, 5001 Av. dos Estados, Bangu, Santo André, SP 09210-580, Brazil
| | - Vicente L Kupfer
- Rinaldi Research Group, Department of Chemistry, State University of Maringá - UEM, 5790 Colombo Avenue, 87020-900, Maringá, PR, Brazil
| | - Jaqueline de C Rinaldi
- Postgraduation in Bioscience and Physiopathology - PBF, State University of Maringá - UEM, 5790 Colombo Avenue, 87020-900, Maringá, PR, Brazil
| | - Erika S Kioshima
- Postgraduation in Bioscience and Physiopathology - PBF, State University of Maringá - UEM, 5790 Colombo Avenue, 87020-900, Maringá, PR, Brazil
| | - Dalmo Mandelli
- Center of Natural and Human Sciences, Federal University of ABC, 5001 Av. dos Estados, Bangu, Santo André, SP 09210-580, Brazil
| | - Marcos R Guilherme
- Rinaldi Research Group, Department of Chemistry, State University of Maringá - UEM, 5790 Colombo Avenue, 87020-900, Maringá, PR, Brazil; Faculty of Engineering and Innovation Professional Technical - FEITEP. Av. Paranavaí, 1164, CEP - 87070-130, Parque Industrial Bandeirantes, Maringá - PR, Brazil
| | - Andrelson W Rinaldi
- Rinaldi Research Group, Department of Chemistry, State University of Maringá - UEM, 5790 Colombo Avenue, 87020-900, Maringá, PR, Brazil.
| |
Collapse
|
37
|
Sun XY, Zhang HJ, Zhao XY, Sun Q, Wang YY, Gao EQ. Dual functions of pH-sensitive cation Zr-MOF for 5-Fu: large drug-loading capacity and high-sensitivity fluorescence detection. Dalton Trans 2021; 50:10524-10532. [PMID: 34259672 DOI: 10.1039/d1dt01772a] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Nanomaterials, as carriers of small molecular drugs, have been a focal point in recent years. In this work, a carbazolyl functionalized metal-organic framework, UiO-67-CDC, was successfully synthesized employing the ligand 9H-carbazole-2,7-dicarboxylic acid (9H-2,7-CDC). Postsynthetic approaches targeted the cationization and replacement of the Lewis base carbazole site with two methyl groups, resulting in the positively charged skeleton, which has proven to be a promising carrier for the anticancer drug 5-fluorouracil (5-Fu). The prepared cationic framework UiO-67-CDC-(CH3)2 showed moderately high surface area, hierarchical pore structures, and positive surface characteristics, which effectively and selectivity encapsulated the electron-rich 5-Fu molecules through electrostatic attraction, with a relatively high loading of up to 56.5% (wt%). The drug delivery in simulated blood environment (pH = 7.4) exhibited a more effective release, demonstrating a physiological pH-responsive sustained release. Significantly, the electron-deficient Zr-MOF itself, as a kind of high-sensitivity fluorescence detector, has a unique fluorescence "turn-on" effect with 5-Fu. These results pave the way towards designing surface-engineered MOF materials of interest in drug delivery and fluorescent sensing applications.
Collapse
Affiliation(s)
- Xi-Yu Sun
- School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, 200241, P. R. China.
| | - Hong-Jing Zhang
- School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, 200241, P. R. China.
| | - Xiao-Yang Zhao
- School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, 200241, P. R. China.
| | - Qian Sun
- School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, 200241, P. R. China.
| | - Yuan-Yuan Wang
- School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, 200241, P. R. China.
| | - En-Qing Gao
- Shanghai Key Laboratory of Green Chemistry and Chemical Processes, School of chemistry and Molecular Engineering, East China Normal University, Shanghai 200062, P. R. China
| |
Collapse
|
38
|
Markopoulou P, Panagiotou N, Li A, Bueno-Perez R, Madden D, Buchanan S, Fairen-Jimenez D, Shiels PG, Forgan RS. Identifying Differing Intracellular Cargo Release Mechanisms by Monitoring In Vitro Drug Delivery from MOFs in Real Time. CELL REPORTS. PHYSICAL SCIENCE 2020; 1:100254. [PMID: 33244524 PMCID: PMC7674849 DOI: 10.1016/j.xcrp.2020.100254] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/11/2020] [Revised: 10/01/2020] [Accepted: 10/16/2020] [Indexed: 05/09/2023]
Abstract
Metal-organic frameworks (MOFs) have been proposed as biocompatible candidates for the targeted intracellular delivery of chemotherapeutic payloads, but the site of drug loading and subsequent effect on intracellular release is often overlooked. Here, we analyze doxorubicin delivery to cancer cells by MIL-101(Cr) and UiO-66 in real time. Having experimentally and computationally verified that doxorubicin is pore loaded in MIL-101(Cr) and surface loaded on UiO-66, different time-dependent cytotoxicity profiles are observed by real-time cell analysis and confocal microscopy. The attenuated release of aggregated doxorubicin from the surface of Dox@UiO-66 results in a 12 to 16 h induction of cytotoxicity, while rapid release of pore-dispersed doxorubicin from Dox@MIL-101(Cr) leads to significantly higher intranuclear localization and rapid cell death. In verifying real-time cell analysis as a versatile tool to assess biocompatibility and drug delivery, we show that the localization of drugs in (or on) MOF nanoparticles controls delivery profiles and is key to understanding in vitro modes of action.
Collapse
Affiliation(s)
- Panagiota Markopoulou
- Joseph Black Building, College of Science and Engineering, School of Chemistry, University of Glasgow, Glasgow G12 8QQ, UK
| | - Nikolaos Panagiotou
- Joseph Black Building, College of Science and Engineering, School of Chemistry, University of Glasgow, Glasgow G12 8QQ, UK
- Wolfson Wohl Cancer Research Centre, College of Medical, Veterinary, & Life Sciences, Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, UK
| | - Aurelia Li
- Adsorption & Advanced Materials Laboratory, Department of Chemical Engineering & Biotechnology, University of Cambridge, Cambridge CB3 0AS, UK
| | - Rocio Bueno-Perez
- Adsorption & Advanced Materials Laboratory, Department of Chemical Engineering & Biotechnology, University of Cambridge, Cambridge CB3 0AS, UK
| | - David Madden
- Adsorption & Advanced Materials Laboratory, Department of Chemical Engineering & Biotechnology, University of Cambridge, Cambridge CB3 0AS, UK
| | - Sarah Buchanan
- Wolfson Wohl Cancer Research Centre, College of Medical, Veterinary, & Life Sciences, Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, UK
| | - David Fairen-Jimenez
- Adsorption & Advanced Materials Laboratory, Department of Chemical Engineering & Biotechnology, University of Cambridge, Cambridge CB3 0AS, UK
| | - Paul G. Shiels
- Wolfson Wohl Cancer Research Centre, College of Medical, Veterinary, & Life Sciences, Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, UK
| | - Ross S. Forgan
- Joseph Black Building, College of Science and Engineering, School of Chemistry, University of Glasgow, Glasgow G12 8QQ, UK
| |
Collapse
|
39
|
Cao J, Li X, Tian H. Metal-Organic Framework (MOF)-Based Drug Delivery. Curr Med Chem 2020; 27:5949-5969. [DOI: 10.2174/0929867326666190618152518] [Citation(s) in RCA: 69] [Impact Index Per Article: 17.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2018] [Revised: 04/05/2019] [Accepted: 05/30/2019] [Indexed: 01/03/2023]
Abstract
Background:
Developing a controllable drug delivery system is imperative and important
to reduce side effects and enhance the therapeutic efficacy of drugs. Metal-organic frameworks
(MOFs) an emerging class of hybrid porous materials built from metal ions or clusters bridged by
organic linkers have attracted increasing attention in the recent years owing to the unique physical
structures possessed, and the potential for vast applications. The superior properties of MOFs, such
as well-defined pore aperture, tailorable composition and structure, tunable size, versatile functionality,
high agent loading, and improved biocompatibility, have made them promising candidates as
drug delivery hosts. MOFs for drug delivery is of great interest and many very promising results
have been found, indicating that these porous solids exhibit several advantages over existing systems.
Objective:
This review highlights the latest advances in the synthesis, functionalization, and applications
of MOFs in drug delivery, and has classified them using drug loading strategies. Finally, challenges
and future perspectives in this research area are also outlined.
Collapse
Affiliation(s)
- Jian Cao
- Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin 300192, China
| | - Xuejiao Li
- Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin 300192, China
| | - Hongqi Tian
- Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin 300192, China
| |
Collapse
|
40
|
Kalaj M, Cohen SM. Postsynthetic Modification: An Enabling Technology for the Advancement of Metal-Organic Frameworks. ACS CENTRAL SCIENCE 2020; 6:1046-1057. [PMID: 32724840 PMCID: PMC7379093 DOI: 10.1021/acscentsci.0c00690] [Citation(s) in RCA: 162] [Impact Index Per Article: 40.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/28/2020] [Indexed: 05/14/2023]
Abstract
Metal-organic frameworks (MOFs) are a class of porous materials with immense chemical tunability derived from their organic and inorganic building blocks. Presynthetic approaches have been used to construct tailor-made MOFs, but with a rather restricted functional group scope limited by the typical MOF solvothermal synthesis conditions. Postsynthetic modification (PSM) of MOFs has matured into an alternative strategy to broaden the functional group scope of MOFs. PSM has many incarnations, but two main avenues include (1) covalent PSM, in which the organic linkers of the MOF are modified with a reagent resulting in new functional groups, and (2) coordinative PSM, where organic molecules containing metal ligating groups are introduced onto the inorganic secondary building units (SBUs) of the MOF. These methods have evolved from simple efforts to modifying MOFs to demonstrate proof-of-concept, to becoming key synthetic tools for advancing MOFs for a range of emerging applications, including selective gas sorption, catalysis, and drug delivery. Moreover, both covalent and coordinative PSM have been used to create hierarchal MOFs, MOF-based porous liquids, and other unusual MOF materials. This Outlook highlights recent reports that have extended the scope of PSM in MOFs, some seminal reports that have contributed to the advancement of PSM in MOFs, and our view on future directions of the field.
Collapse
Affiliation(s)
- Mark Kalaj
- Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California 92093-0358, United States
| | - Seth M. Cohen
- Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California 92093-0358, United States
| |
Collapse
|
41
|
Wang F, Yang J, Li Y, Zhuang Q, Gu J. Efficient enzyme-activated therapy based on the different locations of protein and prodrug in nanoMOFs. J Mater Chem B 2020; 8:6139-6147. [PMID: 32568339 DOI: 10.1039/d0tb01004a] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
Enzyme-activated prodrug therapy (EAPT) is an effective cancer treatment strategy able to transport non-toxic prodrugs and subsequently convert them into drugs at specific times and locations. However, due to the limitation of easy biodegradability and the membrane-impermeable characteristic of exogenous enzymes, there is a need to exploit suitable carriers for the effective protection and simultaneous delivery of activating enzymes into cancer cells. Herein, hierarchically porous MOFs were employed for the loading of enzyme and prodrug in a single nanocarrier thanks to their different cavity sizes. The simple loading process allows entrapping of horseradish peroxidase (HRP) and a monocarboxyl-containing indole-3-acetic acid (IAA) prodrug with high loading capacities in different spaces, which keeps the catalytic activity of the enzyme perfectly intact and avoids the premature activation of the prodrug. The encapsulated HRP and IAA exhibit sustained and synchronized release behaviors. Compared to the native HRP enzyme, the current MOF nanocarriers not only facilitate enzyme delivery into cellular lysosomes and subsequent endosomal escape, but also effectively release enzyme and prodrug in the intracellular environment within 48 h. Eventually, HRP and IAA loaded MOF nanocarriers cause significant cell death with a low IC50 of 4.2 mg L-1, while the IAA prodrug alone is non-toxic even at high concentrations. Thus, hierarchically porous MOFs might offer a promising platform for EAPT with a highly consistent spatiotemporal distribution of enzymes and prodrugs in target tissues.
Collapse
Affiliation(s)
- Fan Wang
- Shanghai Engineering Research Center of Hierarchical Nanomaterials, School of Materials Science and Engineering, East China University of Science and Technology, Shanghai 200237, China.
| | | | | | | | | |
Collapse
|
42
|
Griffin SL, Briuglia ML, ter Horst JH, Forgan RS. Assessing Crystallisation Kinetics of Zr Metal-Organic Frameworks through Turbidity Measurements to Inform Rapid Microwave-Assisted Synthesis. Chemistry 2020; 26:6910-6918. [PMID: 32227534 PMCID: PMC7318326 DOI: 10.1002/chem.202000993] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2020] [Revised: 03/27/2020] [Indexed: 12/29/2022]
Abstract
Controlling the crystallisation of metal-organic frameworks (MOFs), network solids of metal ions or clusters connected by organic ligands, is often hindered by the significant number of synthetic variables inherent to their synthesis. Coordination modulation, the addition of monotopic competing ligands to solvothermal syntheses, can allow tuning of physical properties (particle size, porosity, surface chemistry), enhance crystallinity, and select desired phases, by modifying the kinetics of self-assembly, but its mechanism(s) are poorly understood. Herein, turbidity measurements were used to assess the effects of modulation on the solvothermal synthesis of the prototypical Zr terephthalate MOF UiO-66 and the knowledge gained was applied to its rapid microwave synthesis. The studied experimental parameters-temperature, reagent concentration, reagent aging, metal precursor, water content, and modulator addition-all influence the time taken for onset of nucleation, and subsequently allow microwave synthesis of UiO-66 in as little as one minute. The simple, low cost turbidity measurements align closely with previously reported in situ synchrotron X-ray diffraction studies, proving their simplicity and utility for probing the nucleation of complex materials while offering significant insights to the synthetic chemist.
Collapse
Affiliation(s)
- Sarah L. Griffin
- WestCHEM School of ChemistryUniversity of GlasgowGlasgowUK
- EPSRC Centre for Innovative Manufacturing in, Continuous Manufacturing and Crystallisation (CMAC)Strathclyde Institute of Pharmacy and Biomedical Sciences, Technology and Innovation CentreUniversity of Strathclyde99 George StreetGlasgowUK
| | - Maria L. Briuglia
- EPSRC Centre for Innovative Manufacturing in, Continuous Manufacturing and Crystallisation (CMAC)Strathclyde Institute of Pharmacy and Biomedical Sciences, Technology and Innovation CentreUniversity of Strathclyde99 George StreetGlasgowUK
| | - Joop H. ter Horst
- EPSRC Centre for Innovative Manufacturing in, Continuous Manufacturing and Crystallisation (CMAC)Strathclyde Institute of Pharmacy and Biomedical Sciences, Technology and Innovation CentreUniversity of Strathclyde99 George StreetGlasgowUK
| | - Ross S. Forgan
- WestCHEM School of ChemistryUniversity of GlasgowGlasgowUK
| |
Collapse
|
43
|
|
44
|
Haddad S, Abánades Lázaro I, Fantham M, Mishra A, Silvestre-Albero J, Osterrieth JWM, Kaminski Schierle GS, Kaminski CF, Forgan RS, Fairen-Jimenez D. Design of a Functionalized Metal-Organic Framework System for Enhanced Targeted Delivery to Mitochondria. J Am Chem Soc 2020; 142:6661-6674. [PMID: 32182066 PMCID: PMC7146860 DOI: 10.1021/jacs.0c00188] [Citation(s) in RCA: 83] [Impact Index Per Article: 20.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2020] [Indexed: 12/27/2022]
Abstract
Mitochondria play a key role in oncogenesis and constitute one of the most important targets for cancer treatments. Although the most effective way to deliver drugs to mitochondria is by covalently linking them to a lipophilic cation, the in vivo delivery of free drugs still constitutes a critical bottleneck. Herein, we report the design of a mitochondria-targeted metal-organic framework (MOF) that greatly increases the efficacy of a model cancer drug, reducing the required dose to less than 1% compared to the free drug and ca. 10% compared to the nontargeted MOF. The performance of the system is evaluated using a holistic approach ranging from microscopy to transcriptomics. Super-resolution microscopy of MCF-7 cells treated with the targeted MOF system reveals important mitochondrial morphology changes that are clearly associated with cell death as soon as 30 min after incubation. Whole transcriptome analysis of cells indicates widespread changes in gene expression when treated with the MOF system, specifically in biological processes that have a profound effect on cell physiology and that are related to cell death. We show how targeting MOFs toward mitochondria represents a valuable strategy for the development of new drug delivery systems.
Collapse
Affiliation(s)
- Salame Haddad
- Adsorption
& Advanced Materials Laboratory (AAML), Department of Chemical
Engineering & Biotechnology, University
of Cambridge, Philippa Fawcett Drive, Cambridge CB3 0AS, U.K.
| | - Isabel Abánades Lázaro
- WestCHEM
School of Chemistry, University of Glasgow, Joseph Black Building, University
Avenue, Glasgow G12 8QQ, U.K.
| | - Marcus Fantham
- Laser
Analytics Group, Department of Chemical Engineering & Biotechnology, University of Cambridge, Philippa Fawcett Drive, Cambridge CB3 0AS, U.K.
| | - Ajay Mishra
- Cambridge
Infinitus Research Centre, Department of Chemical Engineering &
Biotechnology, University of Cambridge, Philippa Fawcett Drive, Cambridge CB3 0AS, U.K.
| | - Joaquin Silvestre-Albero
- Laboratorio
de Materiales Avanzados, Departamento de Química Inorgánica-Instituto
Universitario de Materiales, Universidad
de Alicante, E-03690 San Vicente del Raspeig, Spain
| | - Johannes W. M. Osterrieth
- Adsorption
& Advanced Materials Laboratory (AAML), Department of Chemical
Engineering & Biotechnology, University
of Cambridge, Philippa Fawcett Drive, Cambridge CB3 0AS, U.K.
| | - Gabriele S. Kaminski Schierle
- Molecular
Neuroscience Group, Department of Chemical Engineering & Biotechnology, University of Cambridge, Philippa Fawcett Drive, Cambridge CB3 0AS, U.K.
| | - Clemens F. Kaminski
- Laser
Analytics Group, Department of Chemical Engineering & Biotechnology, University of Cambridge, Philippa Fawcett Drive, Cambridge CB3 0AS, U.K.
| | - Ross S. Forgan
- WestCHEM
School of Chemistry, University of Glasgow, Joseph Black Building, University
Avenue, Glasgow G12 8QQ, U.K.
| | - David Fairen-Jimenez
- Adsorption
& Advanced Materials Laboratory (AAML), Department of Chemical
Engineering & Biotechnology, University
of Cambridge, Philippa Fawcett Drive, Cambridge CB3 0AS, U.K.
| |
Collapse
|
45
|
Forgan RS. Modulated self-assembly of metal-organic frameworks. Chem Sci 2020; 11:4546-4562. [PMID: 34122913 PMCID: PMC8159241 DOI: 10.1039/d0sc01356k] [Citation(s) in RCA: 88] [Impact Index Per Article: 22.0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2020] [Accepted: 04/03/2020] [Indexed: 11/29/2022] Open
Abstract
Exercising fine control over the synthesis of metal-organic frameworks (MOFs) is key to ensuring reproducibility of physical properties such as crystallinity, particle size, morphology, porosity, defectivity, and surface chemistry. The principle of modulated self-assembly - incorporation of modulator molecules into synthetic mixtures - has emerged as the primary means to this end. This perspective article will detail the development of modulated synthesis, focusing primarily on coordination modulation, from a technique initially intended to cap the growth of MOF crystals to one that is now used regularly to enhance crystallinity, control particle size, induce defectivity and select specific phases. The various mechanistic driving forces will be discussed, as well as the influence of modulation on physical properties and how this can facilitate potential applications. Modulation is also increasingly being used to exert kinetic control over self-assembly; examples of phase selection and the development of new protocols to induce this will be provided. Finally, the application of modulated self-assembly to alternative materials will be discussed, and future perspectives on the area given.
Collapse
Affiliation(s)
- Ross S Forgan
- WestCHEM School of Chemistry, University of Glasgow Glasgow UK
| |
Collapse
|
46
|
Abánades Lázaro I, Wells CJR, Forgan RS. Multivariate Modulation of the Zr MOF UiO-66 for Defect-Controlled Combination Anticancer Drug Delivery. Angew Chem Int Ed Engl 2020; 59:5211-5217. [PMID: 31950568 PMCID: PMC7154787 DOI: 10.1002/anie.201915848] [Citation(s) in RCA: 145] [Impact Index Per Article: 36.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2019] [Indexed: 01/05/2023]
Abstract
Metal-organic frameworks (MOFs) are emerging as leading candidates for nanoscale drug delivery, as a consequence of their high drug capacities, ease of functionality, and the ability to carefully engineer key physical properties. Despite many anticancer treatment regimens consisting of a cocktail of different drugs, examples of delivery of multiple drugs from one MOF are rare, potentially hampered by difficulties in postsynthetic loading of more than one cargo molecule. Herein, we report a new strategy, multivariate modulation, which allows incorporation of up to three drugs in the Zr MOF UiO-66 by defect-loading. The drugs are added to one-pot solvothermal synthesis and are distributed throughout the MOF at defect sites by coordination to the metal clusters. This tight binding comes with retention of crystallinity and porosity, allowing a fourth drug to be postsynthetically loaded into the MOFs to yield nanoparticles loaded with cocktails of drugs that show enhancements in selective anticancer cytotoxicity against MCF-7 breast cancer cells in vitro. We believe that multivariate modulation is a significant advance in the application of MOFs in biomedicine, and anticipate the protocol will also be adopted in other areas of MOF chemistry, to easily produce defective MOFs with arrays of highly functionalised pores for potential application in gas separations and catalysis.
Collapse
Affiliation(s)
- Isabel Abánades Lázaro
- WestCHEM School of ChemistryUniversity of GlasgowJoseph Black BuildingUniversity AvenueGlasgowG12 8QQUK
| | - Connor J. R. Wells
- WestCHEM School of ChemistryUniversity of GlasgowJoseph Black BuildingUniversity AvenueGlasgowG12 8QQUK
| | - Ross S. Forgan
- WestCHEM School of ChemistryUniversity of GlasgowJoseph Black BuildingUniversity AvenueGlasgowG12 8QQUK
| |
Collapse
|
47
|
Abánades Lázaro I, Wells CJR, Forgan RS. Multivariate Modulation of the Zr MOF UiO‐66 for Defect‐Controlled Combination Anticancer Drug Delivery. Angew Chem Int Ed Engl 2020. [DOI: 10.1002/ange.201915848] [Citation(s) in RCA: 21] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Affiliation(s)
- Isabel Abánades Lázaro
- WestCHEM School of ChemistryUniversity of GlasgowJoseph Black Building University Avenue Glasgow G12 8QQ UK
| | - Connor J. R. Wells
- WestCHEM School of ChemistryUniversity of GlasgowJoseph Black Building University Avenue Glasgow G12 8QQ UK
| | - Ross S. Forgan
- WestCHEM School of ChemistryUniversity of GlasgowJoseph Black Building University Avenue Glasgow G12 8QQ UK
| |
Collapse
|
48
|
Competitive glucose metabolism as a target to boost bladder cancer immunotherapy. Nat Rev Urol 2020; 17:77-106. [PMID: 31953517 DOI: 10.1038/s41585-019-0263-6] [Citation(s) in RCA: 79] [Impact Index Per Article: 19.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/25/2019] [Indexed: 12/24/2022]
Abstract
Bladder cancer - the tenth most frequent cancer worldwide - has a heterogeneous natural history and clinical behaviour. The predominant histological subtype, urothelial bladder carcinoma, is characterized by high recurrence rates, progression and both primary and acquired resistance to platinum-based therapy, which impose a considerable economic burden on health-care systems and have substantial effects on the quality of life and the overall outcomes of patients with bladder cancer. The incidence of urothelial tumours is increasing owing to population growth and ageing, so novel therapeutic options are vital. Based on work by The Cancer Genome Atlas project, which has identified targetable vulnerabilities in bladder cancer, immune checkpoint inhibitors (ICIs) have arisen as an effective alternative for managing advanced disease. However, although ICIs have shown durable responses in a subset of patients with bladder cancer, the overall response rate is only ~15-25%, which increases the demand for biomarkers of response and therapeutic strategies that can overcome resistance to ICIs. In ICI non-responders, cancer cells use effective mechanisms to evade immune cell antitumour activity; the overlapping Warburg effect machinery of cancer and immune cells is a putative determinant of the immunosuppressive phenotype in bladder cancer. This energetic interplay between tumour and immune cells leads to metabolic competition in the tumour ecosystem, limiting nutrient availability and leading to microenvironmental acidosis, which hinders immune cell function. Thus, molecular hallmarks of cancer cell metabolism are potential therapeutic targets, not only to eliminate malignant cells but also to boost the efficacy of immunotherapy. In this sense, integrating the targeting of tumour metabolism into immunotherapy design seems a rational approach to improve the therapeutic efficacy of ICIs.
Collapse
|
49
|
Giliopoulos D, Zamboulis A, Giannakoudakis D, Bikiaris D, Triantafyllidis K. Polymer/Metal Organic Framework (MOF) Nanocomposites for Biomedical Applications. Molecules 2020; 25:E185. [PMID: 31906398 PMCID: PMC6983263 DOI: 10.3390/molecules25010185] [Citation(s) in RCA: 120] [Impact Index Per Article: 30.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2019] [Revised: 12/23/2019] [Accepted: 12/28/2019] [Indexed: 12/14/2022] Open
Abstract
The utilization of polymer/metal organic framework (MOF) nanocomposites in various biomedical applications has been widely studied due to their unique properties that arise from MOFs or hybrid composite systems. This review focuses on the types of polymer/MOF nanocomposites used in drug delivery and imaging applications. Initially, a comprehensive introduction to the synthesis and structure of MOFs and bio-MOFs is presented. Subsequently, the properties and the performance of polymer/MOF nanocomposites used in these applications are examined, in relation to the approach applied for their synthesis: (i) non-covalent attachment, (ii) covalent attachment, (iii) polymer coordination to metal ions, (iv) MOF encapsulation in polymers, and (v) other strategies. A critical comparison and discussion of the effectiveness of polymer/MOF nanocomposites regarding their synthesis methods and their structural characteristics is presented.
Collapse
Affiliation(s)
- Dimitrios Giliopoulos
- Laboratory of Chemical and Environmental Technology, Department of Chemistry, Aristotle University of Thessaloniki, GR-54124 Thessaloniki, Greece;
| | - Alexandra Zamboulis
- Laboratory of Polymer Chemistry and Technology, Department of Chemistry, Aristotle University of Thessaloniki, GR-54124 Thessaloniki, Greece;
| | - Dimitrios Giannakoudakis
- Laboratory of Chemical and Environmental Technology, Department of Chemistry, Aristotle University of Thessaloniki, GR-54124 Thessaloniki, Greece;
| | - Dimitrios Bikiaris
- Laboratory of Polymer Chemistry and Technology, Department of Chemistry, Aristotle University of Thessaloniki, GR-54124 Thessaloniki, Greece;
| | - Konstantinos Triantafyllidis
- Laboratory of Chemical and Environmental Technology, Department of Chemistry, Aristotle University of Thessaloniki, GR-54124 Thessaloniki, Greece;
| |
Collapse
|
50
|
Shait Mohammed MR, Ahmad V, Ahmad A, Tabrez S, Choudhry H, Zamzami MA, Bakhrebah MA, Ahmad A, Wasi S, Mukhtar H, Khan MI. Prospective of nanoscale metal organic frameworks [NMOFs] for cancer therapy. Semin Cancer Biol 2019; 69:129-139. [PMID: 31866477 DOI: 10.1016/j.semcancer.2019.12.015] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2019] [Revised: 11/16/2019] [Accepted: 12/01/2019] [Indexed: 12/12/2022]
Abstract
Nano metal organic frameworks (NMOFs) belong to the group of nanoporous materials. Over the decades, the conducted researches explored the area for the potential applications of NMOFs in areas like biomedical, chemical engineering and materials science. Recently, NMOFs have been explored for their potential use in cancer diagnosis and therapeutics. The excellent physico-chemical features of NMOFs also make them a potential candiadate to facilitate drug design, delivery and storage against cancer cells. In this review, we have explored the characterstic features, synthesis methods, NMOFs based drug delivery, diagnosis and imaging in various cancer types. In addition to this, we have also pondered on the stability and toxicological concerns of NMOFs. Despite, a significant research has been done for the potential use of NMOFs in cancer diagonostic and therapeutics, more information regarding the stability, in-vivo clearance, toxicology, and pharmacokinetics is still needed to ehnace the use of NMOFs in cancer diagonostic and therapeutics.
Collapse
Affiliation(s)
| | - Varish Ahmad
- Health Information Technology Department,Faculty of Applied Studies, King Abdulaziz University, Jeddah, Saudi Arabia
| | - Abrar Ahmad
- Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia
| | - Shams Tabrez
- King Fahd Medical Research Center (KFMRC), King Abdulaziz University, Jeddah, Saudi Arabia
| | - Hani Choudhry
- Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia; Cancer Metabolism and Epigenetic Unit, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia
| | - Mazin A Zamzami
- Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia; Cancer Metabolism and Epigenetic Unit, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia
| | - Muhammed A Bakhrebah
- Life Science and Environmental Research Institute (KFMRC), King Abdulaziz City of Science and Technology (KACST), Riyadh 11442, Saudi Arabia
| | - Aftab Ahmad
- Health Information Technology Department,Faculty of Applied Studies, King Abdulaziz University, Jeddah, Saudi Arabia
| | - Samina Wasi
- College of Medicine, Department of Biochemistry, Imam Abdul Rahman Bin Faisal Uuniversity, Dammam, Saudi Arabia
| | - Hasan Mukhtar
- Department of Dermatology, University of Wisconsin, Madison, 4385 Medical Sciences Center, 1300 University Avenue, Madison, WI 53706, USA
| | - Mohammad Imran Khan
- Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia; Cancer Metabolism and Epigenetic Unit, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia
| |
Collapse
|